/PRNewswire/ Hagens Berman urges Leidos Holdings, Inc. (NYSE: LDOS) investors to submit their losses now. A securities fraud class action has been filed and.
SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) Hagens Berman urges Ebix, Inc. (NASDAQ:EBIX) investors with significant losses to submit your losses now. .
AstraZeneca PLC (AZN) Securities Fraud Class Action :
The complaint alleges that Defendants misrepresented and omitted to disclose widespread flaws in the design, execution, and results of the company s clinical trials of AstraZeneca s COVID-19 vaccine candidate (AZD1222).
Specifically, Defendants concealed that: (1) a critical manufacturing error resulted in a substantial number of trial participants receiving half the designed dosage; (2) clinical trials consisted of an improper patient makeup that received subtly different treatments undermining any conclusion that could be drawn from the clinical data; (3) certain clinical trial participants had not received a second dose at the designated time points; and (4) the Company failed to include a substantial number of patients over 55 years of age.